The Study of Tirzepatide (LY3298176) in Participants With Obesity (SURMOUNT-1) trial found that tirzepatide at 15 mg per week taken over 72 weeks reduced body weight by 20.9% in those with obesity but without diabetes [9]
However, the label doesn't indicate that vomiting may be frequent and may signal a more serious condition like gastroenteritis, intestinal obstruction or pancreatitis
The Transportation Security Administration (TSA) permits medications in carry-on luggage, and patients do not need to place semaglutide in a quart-sized liquids bag, as it qualifies as a medically necessary liquid
This doesn't mean peptides are worthlessfar from it
M., Sanna, E., Deiana, L., Panzone, F., Contu, P., and Floris, C